Atmo Biosciences
Demystifying the Human GutAtmo Biosciences
The Atmo Gas Capsule is a world first patented solution to accurately profile the gases within the gut, leading to better diagnosis and treatment of patients.
Blog Posts
7th July, 2025
Media Release: Atmo Biosciences and RMIT University granted US patent for Ingestible Gas Sensor Capsule
MELBOURNE AND SYDNEY AUSTRALIA, 15 September 2022: Atmo Biosciences, a clinical stage gut health com...
7th July, 2025
Media Release: Positive Atmo Capsule Clinical Trial Results Published
MELBOURNE AND SYDNEY AUSTRALIA, 5 October 2022: Atmo Biosciences, a clinical stage gut health compan...
7th July, 2025
Media Release: Atmo Biosciences strengthens executive leadership team and Board of Directors
MELBOURNE AND SYDNEY AUSTRALIA, 5 May 2022: Atmo Biosciences Limited, a digital health company devel...
7th July, 2025
Media Release: Atmo Biosciences Appoints Medical Advisory Board
MELBOURNE AND SYDNEY AUSTRALIA, 26 July 2022: Atmo Biosciences, a digital health company developing ...
7th July, 2025
Media Release: Atmo Biosciences closes fully subscribed $8 million Series B funding round
• Capital raise led by existing shareholder Otsuka Pharmaceutical, a leading Japanese pharmaceutical...
7th July, 2025
Media Release: Atmo Biosciences reaches 60 per cent recruitment target in dysmotility pivotal clinical study
• 85 patients recruited in multi-site clinical trial to support a submission for initial U.S. regula...
7th July, 2025
Media Release: Atmo Biosciences recruits first patients in dysmotility pivotal clinical study
• Multi-site clinical trial will support an initial submission for U.S. regulatory clearance around ...
7th July, 2025
Media Release: Atmo Biosciences appoints world-renowned gastroenterologist Professor Eamonn Quigley as Medical Advisory Board Chair
• U.S.-based Professor Quigley brings decades of experience in gastroenterological clinical practice...
7th July, 2025
Media Release: Atmo Biosciences strengthens U.S. focus with new board appointment and establishment of San Diego office
MELBOURNE, AUSTRALIA & SAN DIEGO, USA, 17 April 2023: Atmo Biosciences, a company commercializing th...
7th July, 2025
Media Release: Published trial results find Atmo Gas Capsule can detect changes in regional colonic fermentation in IBS patients
MELBOURNE, AUSTRALIA & SAN DIEGO, USA, 7 July 2023: Atmo Biosciences, a company commercializing the ...